SEC Form 4 · accession 0001209191-15-019671
Ocugen, Inc. · OCGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin McArdle
Officer — Chief Financial Officer
Period of report
Feb 26, 2015
Accepted (ET)
Feb 27, 2015 · 5:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001372299
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $9.96 | Feb 26, 2015 | A | 27,000 | A | — | Feb 26, 2025 | Common Stock | 27,000 | 27,000 | D |
| Employee Stock Option (Right to Buy)F2 | $9.96 | Feb 26, 2015 | A | 30,000 | A | — | Feb 26, 2025 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1This option vests over four (4) years of service following February 26, 2016, with twenty-five percent (25%) vesting upon completion of one (1) year of continuous service and in thirty-six (36) equal monthly installments thereafter.
- F2This option shall vest in full if the Issuer's Common Stock price reaches $19.92 per shares or above for any consecutive sixty (60) day period within four (4) years of the date of grant (the "Vesting Date"). In addition, if this option is exercised within one (1) year of the Vesting Date, the Reporting Person must hold shares (net of taxes) until the one (1) year anniversary of the Vesting Date.